{"id":10062,"date":"2018-04-06T05:00:51","date_gmt":"2018-04-06T09:00:51","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10062"},"modified":"2018-04-05T14:08:40","modified_gmt":"2018-04-05T18:08:40","slug":"ohio-bans-gag-orders-in-pbm-contracts-3-things-to-know","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10062","title":{"rendered":"Ohio bans &#8216;gag orders&#8217; in PBM contracts: 3 things to know"},"content":{"rendered":"<p>(By Mackenzie Bean for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>The Ohio Department of Insurance issued a bulletin April 4 to boost drug price transparency for Ohio residents.<\/p>\n<p>Here are three things to know. <a href=\"https:\/\/www.beckershospitalreview.com\/supply-chain\/ohio-bans-gag-orders-in-pbm-contracts-3-things-to-know.html\">Continue reading article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10021\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-768x512.jpg 768w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-1024x683.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Mackenzie Bean for Becker&#8217;s Hospital Review) The Ohio Department of Insurance issued a bulletin April 4 to boost drug<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,10,15],"tags":[],"class_list":["post-10062","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10062"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10062\/revisions"}],"predecessor-version":[{"id":10063,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10062\/revisions\/10063"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}